Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Anterior pituitary hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatomedin |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Antidiuretic hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Panhypopituitarism - anterior and posterior |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
X-linked panhypopituitarism (disorder) |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Prepuberal panhypopituitarism |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Panhypopituitarism |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Pituitary dwarfism with small sella turcica |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Idiopathic panhypopituitarism |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Post-birth injury panhypopituitarism |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Post-infarction panhypopituitarism |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
anden specificeret panhypopituitarisme |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
panhyperpituitarisme, ikke nærmere specificeret |
Interprets |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Hormone radioassay - pituitary |
Component |
True |
Pituitary hormone |
Inferred relationship |
Some |
1 |
kortikotropinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing melatonin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
humant væksthormon, rekombinant præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Hormone-induced hypopituitarism |
Causative agent |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
kortikotropiner |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Posterior pituitary hormones |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Pituitary (posterior lobe) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatrophic hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing anterior pituitary hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatropin (substance) |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing somatotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing pituitary hormone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pituitary hormone |
Inferred relationship |
Some |
1 |
Pituitary luteinizing hormone |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
præparat baseret på hypofyseforlapsekstrakt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing corticotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Posterior pituitary hormone |
Is a |
True |
Pituitary hormone |
Inferred relationship |
Some |
|
Macroprolactin (substance) |
Is a |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing follitropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing follitropin beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing sermorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
sermorelinacetat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
kortikotropinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing melatonin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
kortikotropiner |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 75 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 150 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon beta 600 IE/0,72 ml cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon beta 300 IE/0,36 ml cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon alfa 37,5 IE pulver og solvens til injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon beta 100 IE/ml injektionsvæske, opløsning, hætteglas a 0,5ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon beta 200 IE/ml injektionsvæske, opløsning, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon beta 300 IE/ml injektionsvæske, opløsning, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
rekombinant humant follikelstimulerende hormon beta 400 IE/ml injektionsvæske, opløsning, hætteglas a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing tetracosactide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
cosyntropin 250 µg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
cosyntropin 1 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 1,8 IE (0,6 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 1,2 IE (0,4 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 0,6 IE (0,2 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rmc) 24 IE (8 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 16 IE (5,33 mg), pulver til injektionsvæske, rekonstitution + solvens + injektionssæt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 12 IE (4 mg) pulver og solvens til injektionsvæske, opløsning, fyldt sprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 2,4 IE (0,8 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 3 IE (1 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 16 IE (5,33 mg), pulver til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 16 IE (5,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rmc) 10 IE (3,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rmc) 4 IE (1,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 4 IE (1,33 mg), pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatropin 12 mg powder for solution for injection cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 18 IE (6 mg), pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 36 IE (12 mg), pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 72 IE (24 mg), pulver og solvens til injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
sermorelin 50 µg pulver og solvens til injektionsvæske, opløsning, ampuller |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 3,6 IE (1,2 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 4,2 IE (1,4 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 4,8 IE (1,6 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 5,4 IE (1,8 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 6 IE (2 mg), pulver og solvens til injektionsvæske, opløsning i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (epr) 3,33 mg/ml injektionsvæske, opløsning, cylinderampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (epr) 6,66 mg/ml injektionsvæske, opløsning, cylinderampul à 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (epr) 10 mg/ml injektionsvæske, opløsning, cylinderampul à 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 4 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 8,8 mg pulver til injektionsvæske, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 13,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 18 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin 22,5 mg/3 ml injektionsvæske, opløsning, hætteglas a 3 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Somatrophic hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
somatropin (rbe) 5 mg (15 IE)/ml, injektionsvæske, opløsning, cylinderampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin alfa 300 IE injektionsvæske, opløsning i fyldt pen a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin alfa 450 IE injektionsvæske, opløsning i fyldt pen a 0,75 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin alfa 900 IE injektionsvæske, opløsning i fyldt pen a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
cosyntropin 25 µg + mannitol 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing somatrem (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing pituitary gonadotropin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
cosyntropinpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
humant væksthormon, rekombinant præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Bovine growth hormone recombinant preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
sometribovepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing human menopausal gonadotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing somatotropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
kortikotropinzinkhydroxidpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
præparat baseret på hypofyseforlapsekstrakt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing prolactin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
kortikotropin 80 enheder/ml i gelatine, injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
Product containing somatropin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|
follitropin beta 300 IE injektionsvæske, opløsning, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pituitary hormone |
Inferred relationship |
Some |
|